Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation
Bone Marrow Transplantation, Published online: 24 February 2024; doi:10.1038/s41409-024-02247-wRituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation
Source: Bone Marrow Transplantation - Category: Hematology Authors: Maria Chiara Finazzi Alessandra Weber Chiara Pavoni Anna Grassi Maria Caterina Mic ò Alessandra Algarotti Federico Lussana Alessandro Rambaldi Source Type: research
More News: Bone Marrow Transplant | Hematology | Rituxan | Stem Cell Therapy | Stem Cells | Transplants